Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Primary gastrointestinal stromal tumor of the liver with lung metastases successfully treated with STI-571 (imatinib mesylate).

De Chiara A, De Rosa V, Lastoria S, Franco R, Botti G, Iaffaioli VR, Apice G.

Front Biosci. 2006 Jan 1;11:498-501.

PMID:
16146747
2.

Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.

Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C.

Anticancer Drugs. 2008 Jul;19(6):607-12. doi: 10.1097/CAD.0b013e32830138f9.

PMID:
18525320
4.

[A successfully resected case of liver metastasis of gastrointestinal stromal tumor responding to neoadjuvant chemotherapy with imatinib mesylate and interventional radiology].

Tamura J, Nakayama Y, Kitaguchi K, Ura K, Taira K, Ooe H, Yoshikawa A, Ishigami S, Baba N.

Gan To Kagaku Ryoho. 2009 Oct;36(10):1769-72. Japanese.

PMID:
19838046
5.

[Successful treatment of huge peritoneal metastasis from duodenal gastrointestinal stromal tumor resistant for imatinib mesylate].

Sakakura C, Kumano T, Mizuta Y, Yamaoka N, Sagara Y, Hagiwara A, Otsuji E.

Gan To Kagaku Ryoho. 2007 Nov;34(12):2144-6. Japanese.

PMID:
18219926
6.
7.

A metastatic case of gastrointestinal stromal tumor (GIST) treated with imatinib mesylate (Glivec(®)) in Mali.

Diallo DA, Ly M, Diallo G, Dembélé AK, Touré M, Touré BA, Koné A, Sidibé S, Dembelé M, Traore BC.

Clin Res Hepatol Gastroenterol. 2011 Oct;35(10):675-7. doi: 10.1016/j.clinre.2011.04.012. Epub 2011 Jun 8.

PMID:
21641899
8.

Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate.

Boruban C, Sencan O, Akmansu M, Atik ET, Ozbek S.

Anticancer Drugs. 2007 Sep;18(8):969-72.

PMID:
17667604
9.
10.

Gastrointestinal stromal tumour treated with neoadjuvant imatinib.

Loughrey MB, Mitchell C, Mann GB, Michael M, Waring PM.

J Clin Pathol. 2005 Jul;58(7):779-81.

11.

Immunohistochemical and genetic features of gastric and metastatic liver gastrointestinal stromal tumors: sequential analyses.

Kikuchi H, Yamashita K, Kawabata T, Yamamoto M, Hiramatsu Y, Kondo K, Baba M, Ohta M, Kamiya K, Tanaka T, Suzuki S, Kitagawa K, Kitagawa M, Sugimura H, Konno H.

Cancer Sci. 2006 Feb;97(2):127-32. Erratum in: Cancer Sci. 2006 Apr;97(4):340.

12.

[Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)].

Yamanaka H, Mizushima T, Mikata S, Ito T, Nonaka K, Ide H, Michiura T, Kainuma S, Iwase K.

Gan To Kagaku Ryoho. 2005 Dec;32(13):2125-8. Japanese.

PMID:
16352942
13.
14.

Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.

Rutkowski P, Debiec-Rychter M, Nowecki ZI, Wozniak A, Michej W, Limon J, Siedlecki JA, Jerzak Vel Dobosz A, Grzesiakowska U, Nasierowska-Guttmejer A, Sygut J, Nyckowski P, Krawczyk M, Ruka W.

Med Sci Monit. 2007 Nov;13(11):CR515-522.

PMID:
17968300
15.

[A case of gastric gastrointestinal stromal tumor operated after low-dose chemotherapy with imatinib mesylate].

Hori K, Hanada N, Kusano S, Tsurumoto Y, Sakashita N, Uchino R.

Gan To Kagaku Ryoho. 2008 Oct;35(10):1749-51. Japanese.

PMID:
18931581
16.

Pathological changes related to Imatinib treatment in a patient with a metastatic gastrointestinal stromal tumour.

Abdulkader I, Cameselle-Teijeiro J, Forteza J.

Histopathology. 2005 Apr;46(4):470-2. No abstract available.

PMID:
15810964
17.

Pathology of gastrointestinal stromal tumors.

Hirota S, Isozaki K.

Pathol Int. 2006 Jan;56(1):1-9. Review.

PMID:
16398673
18.

Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: a case report.

Ciresa M, D'Angelillo RM, Ramella S, Cellini F, Gaudino D, Stimato G, Fiore M, Greco C, Nudo R, Trodella L.

Tumori. 2009 Mar-Apr;95(2):236-9.

19.

Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.

Liegl B, Hornick JL, Antonescu CR, Corless CL, Fletcher CD.

Am J Surg Pathol. 2009 Feb;33(2):218-26. doi: 10.1097/PAS.0b013e31817ec2e6.

PMID:
18830121
20.

[A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib].

Sakakura C, Miyagawa K, Fukuda K, Kin S, Nakase Y, Kuriu Y, Nakashima S, Yoshikawa T, Yamaoka N, Sagara Y, Hagiwara A, Yamagishi H.

Gan To Kagaku Ryoho. 2005 Oct;32(11):1739-41. Japanese.

PMID:
16315926

Supplemental Content

Support Center